[{"orgOrder":0,"company":"Alastin Skincare","sponsor":"Galderma","pharmaFlowCategory":"D","therapeuticArea":"Dermatology","country":"","productType":"Peptide","year":"2022","type":"Acquisition","leadProduct":"Herbal Extract","moa":"","graph1":"Dermatology","graph2":"Approved","graph3":"Alastin Skincare","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Topical Cream","sponsorNew":"Alastin Skincare \/ Galderma","highestDevelopmentStatusID":"12","companyTruncated":"Alastin Skincare \/ Galderma"},{"orgOrder":0,"company":"Alastin Skincare","sponsor":"Galderma","pharmaFlowCategory":"D","therapeuticArea":"Dermatology","country":"","productType":"Peptide","year":"2021","type":"Acquisition","leadProduct":"Herbal Extract","moa":"","graph1":"Dermatology","graph2":"Approved","graph3":"Alastin Skincare","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Topical Cream","sponsorNew":"Alastin Skincare \/ Galderma","highestDevelopmentStatusID":"12","companyTruncated":"Alastin Skincare \/ Galderma"}]

Find Clinical Drug Pipeline Developments & Deals by Alastin Skincare

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          euroPLX 86 Munich
                          Not Confirmed
                          euroPLX 86 Munich
                          Not Confirmed

                          Details : ALASTIN’s synergistic portfolio in skincare will increase Galderma’s ability to serve the needs by the patented TriHex Technology®, a blend of peptides (Palmitoyl Tripeptide-1,Myristoyl Tripeptide-1) and active botanicals to support the appearance o...

                          Brand Name : Alastin Skincare

                          Molecule Type : Peptide

                          Upfront Cash : Undisclosed

                          January 05, 2022

                          Lead Product(s) : Palmitoyl Tripeptide-1,Myristoyl Tripeptide-1,Herbal Extract

                          Therapeutic Area : Dermatology

                          Highest Development Status : Approved

                          Sponsor : Galderma

                          Deal Size : Undisclosed

                          Deal Type : Acquisition

                          blank

                          02

                          euroPLX 86 Munich
                          Not Confirmed
                          euroPLX 86 Munich
                          Not Confirmed

                          Details : ALASTIN’s product offerings are backed by the patented TriHex Technology®, a proprietary blend of peptides and active botanicals to support the appearance of rejuvenated skin, which will now be apart of Galderma.

                          Brand Name : Alastin Skincare

                          Molecule Type : Peptide

                          Upfront Cash : Undisclosed

                          November 29, 2021

                          Lead Product(s) : Palmitoyl Tripeptide-1,Myristoyl Tripeptide-1,Herbal Extract

                          Therapeutic Area : Dermatology

                          Highest Development Status : Approved

                          Sponsor : Galderma

                          Deal Size : Undisclosed

                          Deal Type : Acquisition

                          blank